These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20925437)

  • 1. Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
    Aronson JK; Ferner RE
    Drug Saf; 2010 Nov; 33(11):995-1002. PubMed ID: 20925437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventability of drug-related harms - part I: a systematic review.
    Ferner RE; Aronson JK
    Drug Saf; 2010 Nov; 33(11):985-94. PubMed ID: 20925436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIDOS: a mechanistic classification of adverse drug effects.
    Ferner RE; Aronson JK
    Drug Saf; 2010 Jan; 33(1):15-23. PubMed ID: 20000863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the preventability of adverse drug reactions in France: A 2015 overview.
    Olivier-Abbal P
    Therapie; 2016 Apr; 71(2):195-202. PubMed ID: 27080838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and preventability of adverse drug events among older persons in the ambulatory setting.
    Gurwitz JH; Field TS; Harrold LR; Rothschild J; Debellis K; Seger AC; Cadoret C; Fish LS; Garber L; Kelleher M; Bates DW
    JAMA; 2003 Mar; 289(9):1107-16. PubMed ID: 12622580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse event detection by medical record review is reproducible, but the assessment of their preventability is not.
    Klein DO; Rennenberg RJMW; Koopmans RP; Prins MH
    PLoS One; 2018; 13(11):e0208087. PubMed ID: 30496243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for evaluating adverse drug event preventability in emergency department patients.
    Woo SA; Cragg A; Wickham ME; Peddie D; Balka E; Scheuermeyer F; Villanyi D; Hohl CM
    BMC Med Res Methodol; 2018 Dec; 18(1):160. PubMed ID: 30514232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.
    Sessa M; Rafaniello C; Sportiello L; Mascolo A; Scavone C; Maccariello A; Iannaccone T; Fabrazzo M; Berrino L; Rossi F; Capuano A
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):9-15. PubMed ID: 27875917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a new instrument for detecting preventable adverse drug reactions.
    Benkirane R; Soulaymani-Bencheikh R; Khattabi A; Benabdallah G; Alj L; Sefiani H; Hedna K; Ouammi L; Olsson S; Pal SN
    Drug Saf; 2015 Apr; 38(4):383-93. PubMed ID: 25537235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential risks and prevention, Part 3: Drug-induced threats to life.
    Marcellino K; Kelly WN
    Am J Health Syst Pharm; 2001 Aug; 58(15):1399-405. PubMed ID: 11494784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients.
    Calderón-Ospina C; Bustamante-Rojas C
    Int J Pharm Pract; 2010 Aug; 18(4):230-5. PubMed ID: 20636675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harms from medicines: inevitable, in error or intentional.
    Ferner RE
    Br J Clin Pharmacol; 2014 Mar; 77(3):403-9. PubMed ID: 23683079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug events and medication errors: detection and classification methods.
    Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
    Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions.
    Sessa M; Rossi C; Rafaniello C; Mascolo A; Cimmaruta D; Scavone C; Fiorentino S; Grassi E; Reginelli A; Rotondo A; Sportiello L
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):51-59. PubMed ID: 27855534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach.
    Karimian Z; Kheirandish M; Javidnikou N; Asghari G; Ahmadizar F; Dinarvand R
    Int J Health Policy Manag; 2018 Dec; 7(12):1090-1096. PubMed ID: 30709084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
    Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
    Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature of preventable adverse drug events in hospitals: a literature review.
    Kanjanarat P; Winterstein AG; Johns TE; Hatton RC; Gonzalez-Rothi R; Segal R
    Am J Health Syst Pharm; 2003 Sep; 60(17):1750-9. PubMed ID: 14503111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.